Signia Hearing Aids

The world’s first natural own voice solution

Signia just released the first products in their Nx line up. And although they have updated just about everything with these new devices, the most exciting addition has to be how they process the users own voice differently than anything else on the market. This is big news as many hearing aid wearers have difficulty getting used to the sound of their own voice, saying it sounds loud and unnatural. As a world’s first, their addition of Signia Nx’s Own Voice Processing (OVP) provides you with a natural sounding own voice combined with optimal perception of all other sounds for the most pleasant, natural listening experience.

Signia Nx’s Other Key Features

  • The Most Advanced Soundscape Processing – Through their binaural beam-forming technology, Signia Nx is able to analyze your environment and provide clear speech understanding and a natural impression in even the loudest situations.
  • Speech in Noise – Thanks to the Speech Quality feature which uses advanced noise suppression technologies, Signia Nx enables you to hear speech more clearly in all situations.
  • Bluetooth Connectivity – With a built in Bluetooth receiver, Signia Nx hearing aids make connecting to your favourite devices even easier.



Taking Rechargeable Batteries to the Next Level

Siemens was one of the pioneers of rechargeable hearing aids when they first launched the eCharger. Following that launch, they were the only major hearing aid manufacturer to make rechargablility a key part of their RIC and BTE products for years. The co-branded Siemens/Signia Cellion hearing aids are the culmination of 6 generations hearing aid technology improvements.

The Cellion introduced the world to the first induction Lithium-ion hearing aid battery. This allows Signia to offer all of the advantages of their previous rechargeable options, but now with a 24 hour battery life. So no matter how long your day is, your hearing aid will make it through.

Watch the Cellion Video


Contact Us for a 2-Week Trial